| |
| |
|
| Insider
Information: |
Jonas Jeffrey M |
| Relationship: |
|
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
128,046 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
128,046 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sage Therapeutics, Inc. |
SAGE |
|
2023-11-28 |
128,046 |
2014-07-23 |
0 |
Premium* |
|
|
Karuna Therapeutics, Inc. |
KRTX |
|
2024-03-18 |
0 |
2023-06-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
48 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SAGE |
Sage Therapeutics, Inc. |
President & CEO |
• • – |
2019-07-25 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
44,115 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Innovation Officer |
• • – |
2021-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
66,330 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Innovation Officer |
• • – |
2021-10-19 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
85,237 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2023-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,100 |
123,408 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
|
– • – |
2023-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
990 |
990 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2023-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
131,981 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
See Remarks |
• • – |
2015-06-15 |
4 |
AS |
$78.22 |
$6,589,283 |
D/D |
(83,374) |
6,000 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
See Remarks |
• • – |
2015-06-16 |
4 |
AS |
$75.51 |
$8,775,137 |
D/D |
(115,226) |
6,000 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
See Remarks |
• • – |
2015-07-23 |
4 |
AS |
$76.79 |
$230,370 |
D/D |
(3,000) |
81,000 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
President & CEO |
• • – |
2017-12-21 |
4 |
AS |
$155.48 |
$33,102,661 |
D/D |
(210,247) |
1,226 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
President & CEO |
• • – |
2017-12-22 |
4 |
AS |
$155.00 |
$1,976,715 |
D/D |
(12,753) |
1,226 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
President & CEO |
• • – |
2019-05-23 |
4 |
AS |
$171.01 |
$9,407,253 |
D/D |
(53,908) |
62,115 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
President & CEO |
• • – |
2019-05-24 |
4 |
AS |
$174.05 |
$7,065,543 |
D/D |
(40,356) |
62,115 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
President & CEO |
• • – |
2019-05-28 |
4 |
AS |
$173.62 |
$14,801,189 |
D/D |
(84,661) |
13,190 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
President & CEO |
• • – |
2019-05-29 |
4 |
AS |
$169.16 |
$183,401 |
D/D |
(1,075) |
12,115 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2023-02-10 |
4 |
AS |
$44.47 |
$519,413 |
D/D |
(11,643) |
121,981 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
|
– • – |
2023-07-03 |
4 |
AS |
$214.61 |
$2,988,799 |
D/D |
(13,810) |
990 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
|
• • – |
2023-08-01 |
4 |
AS |
$194.78 |
$2,704,101 |
D/D |
(13,810) |
990 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
|
• • – |
2023-09-01 |
4 |
AS |
$186.34 |
$2,595,104 |
D/D |
(13,809) |
990 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
See Remarks |
• • – |
2014-07-23 |
4 |
B |
$18.00 |
$108,000 |
D/D |
6,000 |
6,000 |
2.81 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
See Remarks |
• • – |
2015-12-31 |
4 |
B |
$49.56 |
$11,201 |
D/D |
226 |
81,226 |
2.81 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
President & CEO |
• • – |
2019-12-09 |
4 |
B |
$64.20 |
$481,500 |
D/D |
7,500 |
54,530 |
0.01 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
President & CEO |
• • – |
2019-07-25 |
4 |
D |
$161.38 |
$271,925 |
D/D |
(1,685) |
42,430 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Innovation Officer |
• • – |
2021-06-15 |
4 |
D |
$58.80 |
$181,868 |
D/D |
(3,093) |
63,237 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Innovation Officer |
• • – |
2021-10-19 |
4 |
D |
$40.29 |
$176,228 |
D/D |
(4,374) |
80,863 |
0 |
- |
|
48 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
